This study will look at control of blood sugar levels in persons with type 2 diabetes
mellitus currently on chronic dialysis. Researchers will compare blood sugar levels in people
taking semaglutide to people taking "dummy" medicine. The treatment participants get will be
decided randomly.
Participants will need to inject the study medication once a week. The study will last for 1
year and a month. Participants will be asked to wear a sensor that measures blood sugar
levels for a period of 10 days at five different time points during the study.